Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000039

Chief Medical Officer sold 13,000 shares at an average $21.27 ($276,549)

  • Chief Medical Officer acquired 13,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2022-10-25 Option exercise +8,040 $2.10 $16,884 28,756 D
KREHER NERISSA Chief Medical Officer 2022-10-25 Sale −4,942 $20.53 $101,462 23,814 D
KREHER NERISSA Chief Medical Officer 2022-10-25 Sale −2,998 $21.42 $64,215 20,816 D
KREHER NERISSA Chief Medical Officer 2022-10-25 Sale −100 $22.13 $2,213 20,716 D
KREHER NERISSA Chief Medical Officer 2022-10-26 Option exercise +4,960 $2.10 $10,416 25,676 D
KREHER NERISSA Chief Medical Officer 2022-10-26 Sale −643 $21.21 $13,638 25,033 D
KREHER NERISSA Chief Medical Officer 2022-10-26 Sale −4,317 $22.01 $95,021 20,716 D
Derivatives
KREHER NERISSA Chief Medical Officer 2022-10-25 Option exercise · Stock Option (Right to Buy) −8,040 119,682 D
KREHER NERISSA Chief Medical Officer 2022-10-26 Option exercise · Stock Option (Right to Buy) −4,960 114,722 D
Open-market sales · 13,000 sh · avg $21.27 · $276,549
Loading xslF345X03/wf-form4_166691093179410.xml…